Showing 1 - 10 of 19
Persistent link: https://www.econbiz.de/10011673578
Persistent link: https://www.econbiz.de/10011603542
Persistent link: https://www.econbiz.de/10013492846
Persistent link: https://www.econbiz.de/10014330222
Persistent link: https://www.econbiz.de/10003862253
"Recent evidence suggests that Medicare Part D has increased prescription drug use among the elderly, and earlier studies have indicated that increasing market size induces pharmaceutical innovation. This paper assesses the impact of Medicare Part D on pharmaceutical research and development...
Persistent link: https://www.econbiz.de/10003682093
Persistent link: https://www.econbiz.de/10011349269
Persistent link: https://www.econbiz.de/10009710440
This paper investigates the impact of federal extramural research funding on total expenditures for life sciences research and development (R&D) at U.S. universities, to determine whether federal R&D funding spurs funding from non-federal (private and state/local government) sources. We use a...
Persistent link: https://www.econbiz.de/10012463504
Recent evidence suggests that Medicare Part D has increased prescription drug use among the elderly, and earlier studies have indicated that increasing market size induces pharmaceutical innovation. This paper assesses the impact of Medicare Part D on pharmaceutical research and development...
Persistent link: https://www.econbiz.de/10012464790